LSV Asset Management
CRL icon

LSV Asset Management’s Charles River Laboratories CRL Stock Holding History

LSV Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Sell
455,100
-31,500
-6% -$5.61M 0.19% 162
2026
Q1 		$83.9M Buy
486,600
+10,700
+2% +$1.98M 0.18% 174
2025
Q4 		$94.9M Buy
475,900
+178,100
+60% +$32.3M 0.21% 147
2025
Q3 		$46.6M Buy
297,800
+281,900
+1,773% +$44.8M 0.1% 214
2025
Q2 		$2.41M Buy
+15,900
New +$2.12M 0.01% 537
2017
Q4 		– Sell
-26,500
Closed -$2.86M – 983
2017
Q3 		$2.86M Hold
26,500
– – ﹤0.01% 677
2017
Q2 		$2.68M Buy
+26,500
New +$2.44M ﹤0.01% 679

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management's CRL Position: Q2 2026 in Review

LSV Asset Management reduced its Charles River Laboratories (CRL) stake by 6.5% in Q2 2026, selling an estimated $5.61M and leaving 455,100 shares worth $103M. The position accounts for 0.19% of the portfolio, ranked #162.

LSV Asset Management first reported a position in CRL in Q2 2017 and has held it in 7 quarters since. 283 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • LSV Asset Management held 455,100 shares of Charles River Laboratories worth $103M as of Q2 2026.
  • LSV Asset Management sold 31,500 Charles River Laboratories shares in Q2 2026, an estimated $5.61M.
  • Charles River Laboratories made up 0.19% of LSV Asset Management's portfolio in Q2 2026, its #162 holding.
  • LSV Asset Management first reported a position in Charles River Laboratories in Q2 2017 and has held it in 7 quarters since.
  • 283 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.